Display options
Share it on

Genes (Basel). 2017 Feb 09;8(2). doi: 10.3390/genes8020066.

Dynamics of p53: A Master Decider of Cell Fate.

Genes

Qingyin Luo, Jill M Beaver, Yuan Liu, Zunzhen Zhang

Affiliations

  1. Department of Environmental Health and Occupational Medicine, Sichuan University West China School of Public Health, Chengdu 610041, China. [email protected].
  2. College of Food Science, Sichuan Agricultural University, Yaan 625014, China. [email protected].
  3. Biochemistry Ph.D. Program, Florida International University, Miami, FL 33199, USA. [email protected].
  4. Biochemistry Ph.D. Program, Florida International University, Miami, FL 33199, USA. [email protected].
  5. Department of Chemistry and Biochemistry, Florida International University, Miami, FL 33199, USA. [email protected].
  6. Biomolecular Sciences Institute, School of Integrated Sciences and Humanity, Florida International University, Miami, FL 33199, USA. [email protected].
  7. Department of Environmental Health and Occupational Medicine, Sichuan University West China School of Public Health, Chengdu 610041, China. [email protected].

PMID: 28208785 PMCID: PMC5333055 DOI: 10.3390/genes8020066

Abstract

Cellular stress-induced temporal alterations-i.e., dynamics-are typically exemplified  by the dynamics of p53 that serve as a master to determine cell fate. p53 dynamics were initially  identified as the variations of p53 protein levels. However, a growing number of studies have  shown that p53 dynamics are also manifested in variations in the activity, spatial location, and  posttranslational modifications of p53 proteins, as well as the interplay among all p53 dynamical  features. These are essential in determining a specific outcome of cell fate. In this review, we  discuss the importance of the multifaceted features of p53 dynamics and their roles in the cell fate  decision process, as well as their potential applications in p53-based cancer therapy. The review  provides new insights into p53 signaling pathways and their potentials in the development of new  strategies in p53-based cancer therapy.

Keywords: p53 dynamics;  cell fate decision;  cell signaling network

References

  1. Cell Cycle. 2014;13(16):2572-86 - PubMed
  2. Nat Rev Mol Cell Biol. 2012 Mar 14;13(4):208-9 - PubMed
  3. Oncogene. 2017 Mar 9;36(10 ):1451-1460 - PubMed
  4. Sci STKE. 2004 Dec 21;2004(264):pe55 - PubMed
  5. Nature. 2009 Apr 30;458(7242):1127-30 - PubMed
  6. EMBO J. 1993 Feb;12 (2):461-8 - PubMed
  7. Trends Cell Biol. 2008 Apr;18(4):157-64 - PubMed
  8. Proc Natl Acad Sci U S A. 2011 May 31;108(22):8990-5 - PubMed
  9. Mol Syst Biol. 2006;2:2006.0033 - PubMed
  10. Biophys J. 2014 Apr 15;106(8):1792-800 - PubMed
  11. Cell. 2010 Feb 5;140(3):384-96 - PubMed
  12. PLoS One. 2012;7(6):e38164 - PubMed
  13. Oncogene. 2005 Apr 18;24(17):2899-908 - PubMed
  14. Biochim Biophys Acta. 2009 May;1787(5):414-20 - PubMed
  15. Mol Cell. 2008 May 9;30(3):277-89 - PubMed
  16. Cancer Cell. 2005 Jun;7(6):547-59 - PubMed
  17. Nature. 2003 Jan 30;421(6922):499-506 - PubMed
  18. Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12245-50 - PubMed
  19. Genes Dev. 2014 Aug 15;28(16):1739-51 - PubMed
  20. Cell. 2016 Apr 21;165(3):631-42 - PubMed
  21. Cell. 2013 Feb 28;152(5):945-56 - PubMed
  22. J Mol Cell Biol. 2016 Dec 6;:null - PubMed
  23. Mol Cell Biol. 2007 Oct;27(19):6756-69 - PubMed
  24. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4054-9 - PubMed
  25. Oncogene. 2000 Nov 30;19(51):5831-41 - PubMed
  26. PLoS One. 2015 Feb 06;10 (2):e0115635 - PubMed
  27. Nat Rev Cancer. 2009 Oct;9(10 ):749-58 - PubMed
  28. Cell Death Differ. 2016 Oct;23(10):1615-27 - PubMed
  29. EMBO J. 2011 Feb 2;30(3):524-32 - PubMed
  30. Cell. 2010 Jul 9;142(1):89-100 - PubMed
  31. Oncotarget. 2015 Oct 27;6(33):34718-31 - PubMed
  32. Cell Cycle. 2005 Aug;4(8):1060-4 - PubMed
  33. Cancer Res. 2014 Dec 15;74(24):7161-7 - PubMed
  34. Cancer Cell. 2007 Nov;12(5):414-8 - PubMed
  35. Cell. 1992 Jun 26;69(7):1237-45 - PubMed
  36. Mol Syst Biol. 2011 May 10;7:488 - PubMed
  37. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11250-5 - PubMed
  38. Genes Dev. 1998 Sep 15;12(18):2831-41 - PubMed
  39. Cell. 1995 Jan 27;80(2):293-9 - PubMed
  40. Cancer Biol Ther. 2010 Apr 15;9(8):583-4 - PubMed
  41. Nat Rev Cancer. 2009 Oct;9(10):724-37 - PubMed
  42. Oncotarget. 2013 Oct;4(10):1556-71 - PubMed
  43. Nucleic Acids Res. 2014 Jul;42(12 ):7666-80 - PubMed
  44. Cell. 2012 Apr 27;149(3):515-24 - PubMed
  45. Biochim Biophys Acta. 2014 Jan;1843(1):137-49 - PubMed
  46. Science. 2012 Jun 15;336(6087):1440-4 - PubMed
  47. Eur J Cell Biol. 2000 Dec;79(12 ):924-35 - PubMed
  48. Mol Cell Biol. 2004 Aug;24(15):6728-41 - PubMed
  49. Cancer Res. 2016 Oct 15;76(20):5914-5920 - PubMed
  50. Cancer Res. 2006 Aug 1;66(15):7482-9 - PubMed
  51. PLoS One. 2013 Jun 03;8(6):e65242 - PubMed
  52. Cell Death Dis. 2014 May 08;5:e1221 - PubMed
  53. Eur J Cancer. 2016 Mar;55:98-110 - PubMed
  54. Nat Rev Cancer. 2009 May;9(5):371-7 - PubMed
  55. Mol Med Rep. 2017 Feb;15(2):833-838 - PubMed
  56. Mol Cell Biol. 1998 Apr;18(4):1946-55 - PubMed
  57. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9 - PubMed
  58. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10360-5 - PubMed
  59. Science. 2003 Dec 12;302(5652):1972-5 - PubMed
  60. J Biol Chem. 2014 Dec 12;289(50):34862-70 - PubMed
  61. J Biol Chem. 1993 May 5;268(13):9803-10 - PubMed
  62. Cell. 2010 Aug 6;142(3):409-19 - PubMed
  63. Br J Cancer. 2013 Jun 25;108(12 ):2495-504 - PubMed
  64. Oncogene. 2013 Jan 3;32(1):61-9 - PubMed
  65. Curr Opin Cell Biol. 2005 Dec;17(6):631-6 - PubMed

Publication Types

Grant support